Skip to main content
Clinical Trials/NCT05011240
NCT05011240
Unknown
N/A

A Randomized Controlled Trial of Parent-mediated Social-communication Therapy for Young Children at Risk for Neurodevelopmental Difficulties Living in Poverty in Brazil

Faculdade de Medicina do ABC0 sites160 target enrollmentJanuary 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Child Development
Sponsor
Faculdade de Medicina do ABC
Enrollment
160
Primary Endpoint
Change in parent-child interaction synchrony
Last Updated
4 years ago

Overview

Brief Summary

Exposure to adverse environments such as socioeconomic disadvantage and psychosocial deprivation are risk-factors for neurodevelopmental problems in childhood. Children exposed to such environments may benefit from interventions that target social-communication abilities, since these skills act as protective factors for healthy neurodevelopment in vulnerable children. One early childhood intervention that has shown efficacy in improving early social-communication development is Paediatric Autism Communication Therapy (PACT). However, there are no studies testing the efficacy of PACT in Latin American countries where environmental risk factors are common. This randomized controlled trial will test the efficacy of PACT in improving social-communication development in young children at risk for neurodevelopmental difficulties due to living in socio-economically disadvantaged regions of São Paulo, Brazil.

Methods: Participants will be 160 children aged 2 years 0 months to 4 years 11 months with low social-communication abilities and their primary caregivers. Child-caregiver dyads will be recruited from public early childhood education centers in impoverished urban regions of the city of São Paulo, Brazil. Low social-communication abilities will be defined by Standard Scores <84 on the Socialization and/or Communication domains of the Vineland Adaptive Behavior Scales. Child-caregiver dyads will be randomized to receive 12 sessions (five months) of the PACT intervention (N=80) or five months of community support as usual plus psychoeducation (N=80). The primary outcome (parent-child interaction) and secondary outcomes (social-communication abilities assessed with the Vineland, neurophysiological activity during a live social interaction) will be measured pre- and post-intervention. All procedures will be performed in accordance with the CONSORT declaration for non-pharmacological interventions.

Registry
clinicaltrials.gov
Start Date
January 1, 2022
End Date
June 1, 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Alicia Matijasevich

Associate Professor in Preventative Medicine

Faculdade de Medicina do ABC

Eligibility Criteria

Inclusion Criteria

  • aged 2 years 0 months to 4 years 11 months
  • low social-communication abilities indexed by Standardized Scores between 55 to 84 on the Socialization and/or Communication Domains of the Vineland Adaptive Behavior Scales - Third Edition
  • parent/primary caregiver agrees to participate in the trial

Exclusion Criteria

  • known neurological condition such as epilepsy
  • known genetic disorder such as Down Syndrome
  • hearing or visual impairment in the parent or child that could interfere with the intervention
  • self-reported current psychiatric or neurological disorder in the parent that could interfere with the intervention

Outcomes

Primary Outcomes

Change in parent-child interaction synchrony

Time Frame: Change from baseline (week 1, pre-intervention) to 5 month (post-intervention)

Parent-child interaction synchrony will be measured during a 10-minute free-play interaction between the primary caregiver and child and coded using the Dyadic Communication Measure for Autism (DCMA). Synchrony is coded as the proportion of communicative behaviors of the primary caregiver that elicit responses from the child.

Secondary Outcomes

  • Child initiations during parent-child interaction(Change from baseline (week 1, pre-intervention) to 5 month (post-intervention))
  • Change in neurophysiological activity during live social interaction(Change from baseline (week 1, pre-intervention) to 5 month (post-intervention))
  • Change in Internalizing and Externalizing Behavior Problems(Change from baseline (week 1, pre-intervention) to 5 month (post-intervention))
  • Change in Socialization and Communication Domain Standardized Scores on the Vineland Adaptive Behavior Scales - 3(Change from baseline (week 1, pre-intervention) to 5 month (post-intervention))

Similar Trials